Zhong Zhao
Chief Executive Officer at ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Net worth: 120 M $ as of 2024-03-30
Profile
Zhong Zhao is the founder of Zylox-Tonbridge Medical Technology Co., Ltd.
where he currently holds the title of Chairman & Chief Executive Director since 2012.
He is also currently working as an Independent Director at Avinger, Inc. since 2024.
Previously, Dr. Zhao worked as an Associate Director at Guilford Pharmaceuticals, Inc. from 1996 to 2002 and as a Principal Scientist at Cordis Corp.
from 2002 to 2011.
He obtained his doctorate degree from The Johns Hopkins University School of Medicine in 1997.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-04 | 88,860,231 ( 27.37% ) | 110 M $ | 2024-03-30 | |
| 2023-06-29 | 8,020,684 ( 103.08% ) | 10 M $ | 2024-03-30 | |
AVINGER, INC.
4.43% | 2024-03-04 | 75,327 ( 4.43% ) | 233 438 $ | 2024-03-30 |
Zhong Zhao active positions
| Companies | Position | Start |
|---|---|---|
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | Chief Executive Officer | 2012-11-05 |
| AVINGER, INC. | Director/Board Member | 2024-03-04 |
Former positions of Zhong Zhao
| Companies | Position | End |
|---|---|---|
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Corporate Officer/Principal | 2011-07-31 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Corporate Officer/Principal | 2002-05-31 |
Training of Zhong Zhao
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AVINGER, INC. | Health Technology |
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
- Stock Market
- Insiders
- Zhong Zhao
